Sean E. Aeder

Array ( [id] => 8221669 [patent_doc_number] => 20120135879 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-31 [patent_title] => 'Method and Composition for Cancer Diagnosis and Treatment' [patent_app_type] => utility [patent_app_number] => 13/303605 [patent_app_country] => US [patent_app_date] => 2011-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9237 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13303605 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784639 [patent_doc_number] => 20120046195 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'DETECTING BCL-B EXPRESSION IN CANCER AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/285758 [patent_app_country] => US [patent_app_date] => 2011-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 31393 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046195.pdf [firstpage_image] =>[orig_patent_app_number] => 13285758 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7817481 [patent_doc_number] => 20120064101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-15 [patent_title] => 'Compounds and Methods Useful for Detection and Treatment of Cancer' [patent_app_type] => utility [patent_app_number] => 13/284660 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 16868 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0064/20120064101.pdf [firstpage_image] =>[orig_patent_app_number] => 13284660 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8659088 [patent_doc_number] => 20130039917 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-14 [patent_title] => 'DIAGNOSTIC AND THERAPEUTIC TARGET' [patent_app_type] => utility [patent_app_number] => 13/636117 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8748 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13636117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9339822 [patent_doc_number] => 20140066604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-06 [patent_title] => 'MOLECULAR MARKER CUEDC2 PROTEIN FOR PROGNOSTIC DETERMINATION OF BREAST CANCER ENDOCRINOLOGY THERAPY' [patent_app_type] => utility [patent_app_number] => 13/981271 [patent_app_country] => US [patent_app_date] => 2011-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13868 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13981271 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336185 [patent_doc_number] => 20120202888 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'BIOMARKERS OF PROSTATE CANCER AND PREDICTING MORTALITY' [patent_app_type] => utility [patent_app_number] => 13/271164 [patent_app_country] => US [patent_app_date] => 2011-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12073 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13271164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128283 [patent_doc_number] => 20120088683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'Detection of Cancer Cells in Body Fluids' [patent_app_type] => utility [patent_app_number] => 13/251254 [patent_app_country] => US [patent_app_date] => 2011-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14676 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088683.pdf [firstpage_image] =>[orig_patent_app_number] => 13251254 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054169 [patent_doc_number] => 20120076789 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'NUCLEIC ACID AND CORRESPONDING PROTEIN ENTITLED 121P1F1 USEFUL IN TREATMENT AND DETECTION OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/243297 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 101071 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076789.pdf [firstpage_image] =>[orig_patent_app_number] => 13243297 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9055237 [patent_doc_number] => 20130252950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'TARGETING MTOR SUBSTRATES IN TREATING PROLIFERATIVE DISEASES' [patent_app_type] => utility [patent_app_number] => 13/825723 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 72669 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7719838 [patent_doc_number] => 20120009173 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-12 [patent_title] => 'CYTOTOXIC RIBONUCLEASE VARIANTS' [patent_app_type] => utility [patent_app_number] => 13/243373 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13911 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20120009173.pdf [firstpage_image] =>[orig_patent_app_number] => 13243373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626287 [patent_doc_number] => 08795964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'GRM3 mutations and use thereof for the diagnosis and treatment of melanoma' [patent_app_type] => utility [patent_app_number] => 13/825713 [patent_app_country] => US [patent_app_date] => 2011-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 31 [patent_no_of_words] => 23643 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13825713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8637514 [patent_doc_number] => 20130029317 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'METHOD FOR EARLY DIAGNOSIS OF LIVER CANCER AND PREDICTION OF METASTASIS' [patent_app_type] => utility [patent_app_number] => 13/220055 [patent_app_country] => US [patent_app_date] => 2011-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 4040 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13220055 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8457803 [patent_doc_number] => 08293469 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-10-23 [patent_title] => 'Biomarkers downregulated in prostate cancer' [patent_app_type] => utility [patent_app_number] => 13/220082 [patent_app_country] => US [patent_app_date] => 2011-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 31 [patent_no_of_words] => 25438 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13220082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676610 [patent_doc_number] => 08815520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Method for discrimination of metaplasias from neoplastic or preneoplastic lesions' [patent_app_type] => utility [patent_app_number] => 13/137547 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 5462 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 151 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13137547 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784219 [patent_doc_number] => 20120045775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'PHOSPHOSPECIFIC PAK ANTIBODIES AND DIAGNOSTIC KITS' [patent_app_type] => utility [patent_app_number] => 13/212477 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6968 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20120045775.pdf [firstpage_image] =>[orig_patent_app_number] => 13212477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731345 [patent_doc_number] => 20120014872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => ' Novel Method of Diagnosing, Monitoring, Staging, Imaging and Treating Various Cancers' [patent_app_type] => utility [patent_app_number] => 13/211767 [patent_app_country] => US [patent_app_date] => 2011-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9090 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014872.pdf [firstpage_image] =>[orig_patent_app_number] => 13211767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561267 [patent_doc_number] => 20110275100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'SERPIN B 13 AS A MARKER FOR SQUAMOUS CELL CARCINOMA OF THE LUNG' [patent_app_type] => utility [patent_app_number] => 13/186750 [patent_app_country] => US [patent_app_date] => 2011-07-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7413 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275100.pdf [firstpage_image] =>[orig_patent_app_number] => 13186750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003065 [patent_doc_number] => 20130224190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'ANTI-CD19 ANTIBODY HAVING ADCC AND CDC FUNCTIONS AND IMPROVED GLYCOSYLATION PROFILE' [patent_app_type] => utility [patent_app_number] => 13/811045 [patent_app_country] => US [patent_app_date] => 2011-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 21686 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13811045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7574293 [patent_doc_number] => 20110269949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'METHODS AND COMPOSITIONS TO ELICIT MULTIVALENT IMMUNE RESPONSES AGAINST DOMINANT AND SUBDOMINANT EPITOPES, EXPRESSED ON CANCER CELLS AND TUMOR STROMA' [patent_app_type] => utility [patent_app_number] => 13/179042 [patent_app_country] => US [patent_app_date] => 2011-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13239 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20110269949.pdf [firstpage_image] =>[orig_patent_app_number] => 13179042 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8066119 [patent_doc_number] => 20110243967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'MOLECULAR COMPLEXES WHICH MODIFY IMMUNE RESPONSES' [patent_app_type] => utility [patent_app_number] => 13/156964 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 17395 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0243/20110243967.pdf [firstpage_image] =>[orig_patent_app_number] => 13156964 [rel_patent_id] =>[rel_patent_doc_number] =>)